New funding from the Ontario Institute for Cancer Research supports projects developing methods for cancer detection and tools to facilitate better treatment decisions for high-risk cancer patients
December 1, 2021—Toronto— Today the Ontario Institute for Cancer Research (OICR) announced renewed funding for its Adaptive Oncology (AO) research theme, which includes funding for three new research projects with the potential to have rapid clinical impact.
Excerpt from the Press Release:
he Adaptive Oncology theme was developed to anticipate and counter tumour evolution and heterogeneity in space and time by administering the most appropriate therapies at the right time. To achieve this, the initiative brings together OICR researchers with expertise in genomics, bioinformatics, machine learning, imaging, robotics and histopathology in the pursuit of practical approaches for deeply characterizing the diverse properties of tumours and developing clinical tools to detect and adapt treatment strategies accordingly.
“We are very optimistic about the potential of these newly-funded projects. This research uses cutting edge technologies that could have a real impact in how cancer is diagnosed and treated,” says Dr. Lincoln Stein, Head of Adaptive Oncology. “We are thrilled to see how this initiative is maturing and building momentum each year. Several teams funded during previous years have now advanced to the pre-clinical testing phase. The new funding will foster collaborations among our research teams, facilitate knowledge sharing, and accelerate the pace of this research.”
This work supports OICR’s new Strategic Plan 2021-2026, which has a focus on advancing research towards earlier cancer detection and intervention, leveraging Ontario’s global leadership in data sharing and analytics, expanding on Ontario’s robust pipeline of novel cancer therapies and navigating new therapies into clinical use as well as into new commercial opportunities in Ontario. This new group of funded Adaptive Oncology projects helps move towards realizing these goals.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?